STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight

Experts warn easy access to GLP-1 drugs may increase eating disorder risks

Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula

GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates

New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p

Medicare now covering some GLP-1s for $50. Here's what to know

Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels

A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign